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1. Introduction 
Cerebroside sulfate (CS) is an acidic lipid that has 
been identified in amine containing tumor mast cells 
[ 1, 21 . The ability of acidic lipids to form complexes 
in vitro with positively charged organic compounds 
such as 5hydroxytryptamine (5HT) or histamine (H) 
has been noted [3,4] . The present study describes 
the formation in vivo of cerebroside sulfate-amine 
complexes in the HC line of tumor mast cells. 
2. Materials and methods 
HC cells derived from the Furth-Hagen-Hirsch 
mastocytoma [S] were carried in LAF, , female mice 
(Jackson Labs, Bar Harbor, Me.). Seven days after 
the injection of the ascites cells, the tumor bearing 
mice received an intraperitoneal injection of 0.05 PCi 
of 14C-5-HT (sp. act. 56 mCi/mmole) or 14C-hista- 
mine (sp. act. 58 mCi/mmole). Thirty minutes later 
the cells were harvested, suspended in 0.34 M sucrose, 
and sonicated (at 2 A, for 2 mm) at 0”. The sonicate 
was spun at 1,500 g for 10 min to remove whole cells. 
A large particle fraction was collected by centrifuga- 
tion at 5,500g for 10 min. Further purification of 
the fraction was performed on a discontinuous sucrose 
density gradient (0.6-1.5 M, see fig. 1) by centrifuga- 
tion at 204,000 g for 60 min at 0”. Five fractions 
were collected from the top of the tube and aliquots 
of each fraction were assayed for endogenous 5-HT 
and histamine [6-81, and fumarase activity [9] . Cor- 
responding fractions from several gradients were 
SUCROSE DENSITY 
GRADIENT 
F3 ) 1.40 
- (1.5) _ ----- 
F4 '.50(l.o) 
5 u - 
Fig. 1. The fractions collected from the top of the tube were 
designated FL-F5 and each corresponds to a visible band be- 
tween two layers (bands occur between 0.6 M and 1.3 M, 
1.3 M and 1.4 M, and 1.4 M and 1.5 M sucrose). The large 
numbers (in the tube) indicate the sucrose molarities of the 
gradient layers. The numbers in parentheses (1.0) etc., are the 
volumes of the layers. 
pooled, extracted with a lipid solvent [lo] , chroma- 
tographed on a magnesium silicate column [ 111, and 
assayed for cerebroside sulfate content [ 1, 12, 131. 
The 14C-amines were extracted by the same method 
as that used for the endogenous amines, and the 
radioactivity was measured in a liquid scintillation 
counter. 
To determine the presence of CS-amine complexes, 
the fractions from several gradients were pooled and 
extracted with chloroform/methanol [lo] . The chloro- 
form phase was chromatographed by the thin-layer 
method, on silica gel G (Merck), in chloroform/metha- 
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Table 1 
The density gradient distribution of cerebroside sulfate, amines and fumarase from the 5,500 g fraction of HC cells *. 
Fraction % cs RSC t 
F1 26.1 f 2.0 0.98 
F2 58.7 f 5.1 2.70 
F3 2.1 f 0.2 0.17 
F4 5.6 + 0.8 0.55 
F5 7.5 f 0.7 0.29 
% 5-HT RSC t 
14.6 k 0.5 0.52 
14.1 k 0.62 0.62 
8.8 f 0.3 0.71 
6.5 f 0.4 0.54 
55.8 + 1.9 2.16 
% Histamine RSC t 
14.8 f 1.2 0.53 
17.4 + 0.5 0.77 
4.9 + 0.3 0.40 
5.4 + 0.5 0.44 
57.5 + 1.3 2.23 
% Fumarase RSC t 
34.8 f 1.5 1.26 
37.2 f 1.8 1.64 
17.3 f 1.8 1.42 
8.0 f 1.5 0.66 
2.7 +O.l 0.10 
* Values represent he mean of 3 experiments (k standard error of the mean) expressed as percent distribution of the total. 
t Relative specific concentration (RSC) = % of lipid, amines, or fumase./% of total protein. 
nol/water solvent systems [ 141. The cerebroside 
sulfate-amine complexes and other lipid extractable 
compounds were detected by exposure to iodine 
vapor, and after elution the presence of CS compo- 
nents and 14Camines were determined. The identity 
of the 14Camines was determined by thin layer 
chromatography in butanol/acetic acid/water (12:3 : 5) 
[ 151. The S-hydroxytryptamine and histamine stan- 
dards were visualized on the plates by spraying with 
p-dimethylaminobenzaldehyde [171 and diazotized 
sulfanilic acid [ 161 reagents, respectively. 
3. Results 
Chemical analysis of the density gradient fractions 
showed almost complete separation of the amine 
containing particles (F5), from CS and fumarase (F2). 
The bulk of the CS appeared in a fraction that showed 
high fumarase activity, characteristic of mitochondria. 
The endogenous amines were predominantly localized 
in the multivesicular granule fraction (F5) (table 1). 
A significant portion of the exogenous 14C-amines, on 
the other hand, were incorporated into the CS, fuma- 
rase containing fraction (F2). The chlorofomr/metha- 
no1 (2: l), extract prepared from pooled F2 fractions 
from several gradients, showed that about 37% of 
14C-S-HT and 52% of 14Chistamine contained in this 
fraction were extracted into the organic solvent (table 
2). Thin-layer chromatography of the chloroform 
phase showed that about 45% of the radioactivity of 
5-HT and 52% of the radioactivity of histamine were 
located in a band shown to contain CS by chemical 
methods. When the CS-amine complexes were pre- 
pared by mixing their components in vitro and extract- 
ing them into the organic solvent, the complexes were 
almost completely dissociated during chromatography 
(fig. 2). Hydrolysis of the cerebroside sulfate-amine 
Table 2 
The density gradient distribution and the organic solvent extraction of 14C-amines from the 5,500 g fraction of HC cells *. 
% of amine extracted into 
Fraction % 14C-5-HT RSC t % 14C-Histamine RSC t organic solvent 
14C-S-HT 14C-Histamine 
Fl 18.1 + 1.9 0.69 13.5 zk 1.4 0.49 10.3 f 2.7 18.4 f 3.6 
F2 31.7 * 1.7 1.38 36.5 f 1.1 1.59 36.8 + 2.0 51.6 f 3.9 
F3 7.9 + 2.3 0.49 6.9 ? 1.9 0.43 8.4 f 0.3 10.1 + 0.6 
F4 4.3 + 1.0 0.29 4.4 rt 0.8 0.31 4.9 f 0.4 9.3 f 0.7 
Es 38.0 f 1.5 1.82 38.7 f 0.5 1.85 16.9 f 3.9 24.1 f 1.8 
* Values represent he mean of 3 experiments (k standard error of the mean) expressed as percent distribution of the total or 
percent of amine extracted. 
t Relative specific concentration (RSC) = % of 14C-amines/% of total protein. 
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Fig. 2. Thin-layer chromatograms. The left-hand portion of the figure is a chromatogram of the total lipid extract prepared from 
gradient fraction F2. A significant amount of radioactivity (44.8% of S-HT and 51.6% of H) appeared in the cerebroside sulfate 
band. The right hand portion of the figure shows a chromatogram of the G-amine complexes prepared in vifro. The complexes 
appear to be almost completely dissociated with 83.7% of the 5-HT and 85.2% of the histamine remaining at the origin. CS is the 
only spot on the plate, beyond the origin, and contains a small percentage of the radioactivity. 
complexes, formed in viva, with 0.1 N HCI and sub- 
sequent analysis, demonstrated that 85-87s of the 
l‘%radioactivity of the complexes cochromatographed 
with standard histamine or 5-HT. 
4. Discussion 
We have shown that CS is located in a particulate 
fraction of mast cells that is separable from the multi- 
vesicular, amine-containing granules, and therefore 
this compound is probably not involved in the bind- 
ing of biogenic amines in the mast cells storage 
granules. A significant portion of the exogenous 
amines that are taken up by mast cells, however, is 
incorporated into a cell fraction which has a high CS 
content and is rich in the mitochondrial enzyme 
fumarase. This fraction may correspond to the extra- 
granular amine pool in tumor mast cells, reported by 
Green and Furano [ 181. Thin-layer chromatography 
of the chloroform/methanol extract of this fraction 
demonstrated the presence of cerebroside sulfate- 
amine complexes differing from those formed in vitro, 
since the latter dissociate completely upon thin-layer 
chromatography. Cerebroside sulfate-amine complexes 
also occur in X-162 cells derived from the Dunn- 
Potter mastocytoma [ 191. It should be noted that 
these lines of mast cells have no demonstrable mono- 
amine oxidase activity [20, 211. It is possible, there- 
fore, that the formation of the lipid-amine complexes 
in these cell lines may represent an alternate amine 
metabolic step. 
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